---
figid: PMC9075007__nihms-1787464-f0008
figtitle: Working model for the effect of SULF2 monoclonal antibody 5D5 on PDGFRBeta-YAP
  signaling in CCA
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9075007
filename: nihms-1787464-f0008.jpg
figlink: /pmc/articles/PMC9075007/figure/F8/
number: F8
caption: SULF2 increases the activity of the PDGFRβ-YAP pathway to promote tumor growth
  and chemotherapy resistance. Targeting SULF2 by monoclonal antibody 5D5 showed inhibition
  of the PDGFRβ-YAP pathway and CCA growth in a mouse model.
papertitle: SULF2 monoclonal antibody 5D5 suppresses human cholangiocarcinoma xenograft
  growth via regulation of a SULF2-PDGFRβ-YAP signaling axis.
reftext: Xin Luo, et al. Hepatology. ;74(3):1411-1428.
year: '2021'
doi: 10.1002/hep.31817
journal_title: Hepatology (Baltimore, Md.)
journal_nlm_ta: Hepatology
publisher_name: ''
keywords: Bile duct cancer | Tumor microenvironment | Preclinical experiment | Hippo
  pathway | Anticancer Target
automl_pathway: 0.9498407
figid_alias: PMC9075007__F8
figtype: Figure
redirect_from: /figures/PMC9075007__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9075007__nihms-1787464-f0008.html
  '@type': Dataset
  description: SULF2 increases the activity of the PDGFRβ-YAP pathway to promote tumor
    growth and chemotherapy resistance. Targeting SULF2 by monoclonal antibody 5D5
    showed inhibition of the PDGFRβ-YAP pathway and CCA growth in a mouse model.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDGFRB
  - YAP1
  - SULF2
  - TF
  - CCND1
  - MCL1
---
